A Win For Organon & Co.
Fri, Apr 24, 2026 at 07:24 PM
Organon & Co. (OGN:NYSE) shot up at $11.26, representing a gain of 30.9%. On Fri, Apr 24, 2026, OGN:NYSE hit a New 2-Week High of $11.26. The stock appeared on our News Catalysts scanner on Fri, Apr 24, 2026 at 05:17 PM in the 'ACQUISITION' category. From Fri, Apr 10, 2026, the stock recorded 60.00% Up Days and 54.55% Green Days
About Organon & Co. (OGN:NYSE)
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and...
Top 10 Gainers:
- MaxLinear, Inc. (MXL:NASDAQ), 76.12%
- Scinai Immunotherapeutics Ltd. (SCNI:NASDAQ), 61.62%
- Atomera Incorporated (ATOM:NASDAQ), 38.93%
- Elong Power Holding Limited (ELPW:NASDAQ), 35.58%
- Organon & Co. (OGN:NYSE), 30.93%
- Akanda Corp. (AKAN:NASDAQ), 30.52%
- AEye, Inc. (LIDR:NASDAQ), 29.59%
- POET Technologies Inc. (POET:NASDAQ), 28.84%
- Cheetah Net Supply Chain Service Inc. (CTNT:NASDAQ), 28.4%
- Direxion Daily AMD Bull 2X Shares (AMUU:NASDAQ), 27.97%